metformin has been researched along with Anus Neoplasms in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Anus Neoplasms: Tumors or cancer of the ANAL CANAL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients aged 18-65 years with type 2 diabetes mellitus (DM) were evaluated, and cases of AIN were identified." | 1.62 | Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients. ( D'Adamo, CR; Fang, SH; Hsu, AT; Hung, YC; Mavanur, AA; Svoboda, SM; Wolf, JH, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, AT | 1 |
| Hung, YC | 1 |
| Fang, SH | 1 |
| D'Adamo, CR | 1 |
| Mavanur, AA | 1 |
| Svoboda, SM | 1 |
| Wolf, JH | 1 |
1 other study available for metformin and Anus Neoplasms
| Article | Year |
|---|---|
Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients.
Topics: Anus Neoplasms; Carcinoma in Situ; Case-Control Studies; Diabetes Mellitus, Type 2; Humans; Metformi | 2021 |